MetLife Investment Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $729K | Hold |
39,091
| – | – | ﹤0.01% | 1484 |
|
|
2025
Q1 | $749K | Sell |
39,091
-597
| -2% | -$11.4K | ﹤0.01% | 1512 |
|
|
2024
Q4 | $1.43M | Buy |
39,688
+2,266
| +6% | +$81.6K | 0.01% | 1239 |
|
|
2024
Q3 | $1.59M | Buy |
37,422
+21,086
| +129% | +$894K | 0.01% | 1143 |
|
|
2024
Q2 | $658K | Buy |
16,336
+14,722
| +912% | +$593K | ﹤0.01% | 1568 |
|
|
2024
Q1 | $57.2K | Buy |
1,614
+3
| +0.2% | +$106 | ﹤0.01% | 2697 |
|
|
2023
Q4 | $47.7K | Sell |
1,611
-28
| -2% | -$828 | ﹤0.01% | 2772 |
|
|
2023
Q3 | $34K | Buy |
1,639
+2
| +0.1% | +$42 | ﹤0.01% | 2856 |
|
|
2023
Q2 | $40.2K | Sell |
1,637
-2,062
| -56% | -$50.6K | ﹤0.01% | 2906 |
|
|
2023
Q1 | $150K | Sell |
3,699
-39,146
| -91% | -$1.59M | ﹤0.01% | 2379 |
|
|
2022
Q4 | $1.93M | Sell |
42,845
-864
| -2% | -$38.8K | 0.01% | 922 |
|
|
2022
Q3 | $2.09M | Sell |
43,709
-324
| -0.7% | -$15.5K | 0.02% | 853 |
|
|
2022
Q2 | $2.61M | Buy |
44,033
+375
| +0.9% | +$22.2K | 0.02% | 786 |
|
|
2022
Q1 | $5.08M | Buy |
43,658
+12,869
| +42% | +$1.5M | 0.03% | 519 |
|
|
2021
Q4 | $4.63M | Buy |
30,789
+509
| +2% | +$76.6K | 0.04% | 437 |
|
|
2021
Q3 | $3.61M | Buy |
+30,280
| New | +$3.61M | 0.03% | 538 |
|
|
2020
Q2 | – | Sell |
-23,636
| Closed | -$1.52M | – | 2355 |
|
|
2020
Q1 | $1.52M | Sell |
23,636
-1,198
| -5% | -$77.1K | 0.02% | 715 |
|
|
2019
Q4 | $1.48M | Hold |
24,834
| – | – | 0.02% | 930 |
|
|
2019
Q3 | $1.46M | Hold |
24,834
| – | – | 0.02% | 902 |
|
|
2019
Q2 | $1.6M | Buy |
24,834
+2,128
| +9% | +$137K | 0.02% | 907 |
|
|
2019
Q1 | $1.44M | Hold |
22,706
| – | – | 0.02% | 939 |
|
|
2018
Q4 | $862K | Hold |
22,706
| – | – | 0.01% | 1084 |
|
|
2018
Q3 | $973K | Buy |
+22,706
| New | +$973K | 0.01% | 1136 |
|